Conflict of interest Author AA has received consulting fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz and Takeda
It is currently moving through advanced stage 3 clinical trials
Some people have reported serious health events, including hospitalizations, due to taking too much of the drug
If your Mochi Health or Wellness Plus subscription needs to be updated, a member of our care team will reach out to you to confirm
Additional studies are warranted to determine whether these benefits endure following treatment cessation
Injections: A Practical Comparison For patients weighing both options, some real-world differences matter beyond the clinical trial results